About 41% of US adults
have blood vitamin D below the level considered sufficient.
Peer-reviewed analysisDHA (Docosahexaenoic Acid) is the lead active here, studied most for omega 3 index. Magnesium is the most studied active here, with 21 human studies behind it, each one cited. Each serving carries 330 mg of DHA (Docosahexaenoic Acid), inside the range the published research used. Who it fits: made for women, adults.
Verified by IngredientMDThe panel on the left is the one we evaluated, line by line.
All 8 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Strong evidence, strong dose".
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Cross-checked against 1,463 documented interactions for these actives.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
About 41% of US adults
have blood vitamin D below the level considered sufficient.
Peer-reviewed analysisAbout 84% of US adults
take in less vitamin E than the estimated average requirement.
Peer-reviewed analysisAbout 8% of US women aged 19 and over
take in less vitamin B12 from food and drink than the estimated average requirement.
NHANESAbout 48% of Americans
take in less magnesium than recommended from food and drink.
NIH Office of Dietary SupplementsUnder 250 mg a day
US adults average well under the 250 mg a day of EPA and DHA that health authorities suggest for heart health.
Peer-reviewed analysisMore than 97% of US women aged 19 and over
take in less vitamin D from food and drink than the estimated average requirement.
NHANESAbout 85% of US women aged 19 and over
take in less vitamin E from food and drink than the estimated average requirement.
NHANESAbout 18% of US women aged 19 to 50
take in less folate from food and drink than the estimated average requirement.
NHANESMore than 1 in 3 US adults
regularly sleep less than the recommended seven hours a night.
Peer-reviewed analysisMore than 97% of US women aged 51 to 70
take in less vitamin D from food and drink than the estimated average requirement.
NHANESAbout 54% of US women aged 19 to 30
take in less magnesium from food and drink than the estimated average requirement.
NHANESAbout 50% of US women aged 51 to 70
take in less magnesium from food and drink than the estimated average requirement.
NHANESAbout 51% of US women aged 19 and over
take in less magnesium from food and drink than the estimated average requirement.
NHANES74% of US adults
take dietary supplements, and 55% are regular users, in the Council for Responsible Nutrition's 2023 consumer survey of 3,192 adults.
Council for Responsible Nutrition and Ipsos, 202392% of US supplement users
agree that dietary supplements are essential to maintaining their health, in the Council for Responsible Nutrition's 2023 consumer survey.
Council for Responsible Nutrition and Ipsos, 202312.3% of US adults
met the fruit intake recommendation and 10.0% the vegetable recommendation in 2019, in the Behavioral Risk Factor Surveillance System across 49 states.
CDC, MMWR, 202215% of US adults
aged 20 and over ate no breakfast on the day of their dietary recall, in the 2017 to March 2020 What We Eat in America survey.
USDA Agricultural Research Service, 202457.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health Statistics60.2% of US adults aged 20 and over
took a dietary supplement in the past 30 days, and 38.7% took two or more, in the 2021 to 2023 National Health and Nutrition Examination Survey.
CDC National Center for Health Statistics, 202659 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Meta-analysis, 2022
Across nine trials in postmenopausal women, vitamin K2 raised lumbar spine bone density by about 2.2 percent and forearm bone density by about 1.6 percent compared with control.
Journal of Bone and Mineral MetabolismRandomised trial, 2013
In healthy postmenopausal women, three years of 180 micrograms a day of MK-7 slowed bone density loss at the spine and hip, and improved bone strength.
The paperMeta-analysis, 2022
Across 8 trials in 1,002 women, vitamin E taken by mouth reduced reported menstrual cramp pain compared with placebo, with the clearest effect in the first month.
Clinical Nutrition ESPENMeta-analysis, 2025
In nine trials of 2,570 older women with low bone mass, vitamin K2 changed blood signals tied to bone turnover, not actual bone strength.
Front EndocrinolMeta-analysis, 2011
In trials giving DHA by itself, DHA lowered triglycerides and raised HDL cholesterol by about 4.5 mg/dL compared with placebo.
The paperMeta-analysis, 2025
Across six mostly observational studies in 2,327 Japanese adults, habitual natto intake linked to much higher blood MK-7 and modestly greater bone density, a food-intake association, not a measured effect.
Front NutrRandomised trial, 2020
In this trial of a low daily MK-7 amount, bone mineral density changed over the study period in the group given it, an imaging measurement, not a clinical event.
Calcified Tissue InternationalRandomised trial, 2023
In 160 postmenopausal women with long-standing sleep difficulty, one month of vitamin E brought the median sleep questionnaire score to 6, versus 9 on placebo, where lower means better sleep.
NutrientsMeta-analysis, 2024
Across 10 trials in 318 athletes, vitamin D3 raised blood vitamin D by about 14.8 nmol/L and hinted at better muscle strength, though few trials leave that uncertain.
Frontiers in NutritionMeta-analysis, 2014
Pooling 30 trials of 5,615 adults, vitamin D gave a small rise in overall muscle strength, with no measurable effect on muscle mass or power.
Journal of Clinical Endocrinology and MetabolismRandomised trial, 2025
Vitamin D3 supplementation changed the inflammatory protein CHI3L1 and oxidative stress markers in adults with a chronic demyelinating condition. These are markers, not clinical outcomes.
Neuropsychopharmacology ReportsMeta-analysis, 2025
Across 21 trials, vitamin E lowered oxidized LDL and lengthened the time before LDL starts to oxidize, by about 20.45 units, both lab markers of oxidation.
European Journal of PharmacologyMeta-analysis, 2026
Across 9 placebo-controlled eccentric exercise trials in healthy adults, supplements combining DHA with EPA reduced delayed onset muscle soreness (Hedges g -0.75, 95% CI -1.14 to -0.36). The wider body of 43 studies was mixed, and the trials tested the two fats together rather than DHA alone.
NutrientsMeta-analysis, 2024
Across 20 studies, daily vitamin D3 raised blood vitamin D levels by about 10.4 nmol/L more than the same dose of vitamin D2, roughly 40 percent more.
Advances in NutritionMeta-analysis, 2012
In trials directly comparing the two forms, vitamin D3 raised blood 25-hydroxyvitamin D more than vitamin D2 did (P = 0.001).
American Journal of Clinical NutritionMeta-analysis, 2015
Across 12 trials, vitamin E lowered a blood marker of inflammation by about 0.62 mg/l compared with not taking it.
European Journal of Clinical NutritionMeta-analysis, 2023
Across 12 trials in 794 adults with high liver fat, at least 400 IU of vitamin E daily lowered two liver enzyme markers by 7 to 10 and 5 units.
NutrientsMeta-analysis, 2014
Across 23 trials of 4,082 adults, vitamin D raised bone mineral density at the femoral neck by about 0.8%, with no measurable change at the spine, hip, or other sites.
LancetSystematic review, 2026
The authors report that effects on glycaemic measures differ across groups with differing baseline blood sugar status, so results are not uniform across populations. The outcomes assessed are blood markers.
NutrientsRandomised trial, 2010
Formula-fed infants given DHA-enriched formula from 0.32% of fatty acids developed better visual acuity by 12 months than infants on DHA-free formula.
American Journal of Clinical NutritionMeta-analysis, 2024
Pooling 9 randomised trials of DHA given before or after birth, infants in the DHA groups scored 1.47 points higher on the Psychomotor Development Index (95% CI 0.23 to 2.72), with no difference detected on the Mental Development Index.
Frontiers in NeurologyMeta-analysis, 2026
Pooling the available trials, adjuvant vitamin E alongside varicocele surgery was associated with better post-operative semen parameters, which are laboratory markers of sperm quality and not fertility outcomes.
Archivio Italiano di Urologia e AndrologiaMeta-analysis, 2022
Across 71 trials, omega-3 (DHA and EPA together) at 2 to 3 grams a day lowered the top blood pressure number by about 2.6 points.
Journal of the American Heart AssociationRandomised trial, 2026
In 26 amateur runners, 12 weeks of DHA and EPA raised red blood cell omega-3 levels while placebo stayed the same, blood markers not performance outcomes.
Prostaglandins, Leukotrienes and Essential Fatty AcidsPopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
One pairing in this formula has been studied as a combination in human trials. Each finding below is what a named study measured, cited and dated, never written by the brand.
In a meta-analysis of eight randomized trials, vitamin K2 taken together with vitamin D raised total bone mineral density and lowered undercarboxylated osteocalcin, a marker of vitamin K status.
Research strength. Research strength says how much work stands behind the combination. It is never a product score.
Fail closed. Where actives were studied on their own rather than together, each shows on its own evidence, never a combined effect no trial measured.
Independent record. Every finding is cited to a named trial, dated, and never written by the brand.
Findings from trials that studied these actives as a combination. Context for how the actives were tested together, not a statement about any individual and not a claim about this product.
Time-to-effect windows the engine read from the trial record. Each is a window a named study measured, cited and dated, never written by the brand.
In the trial record, blood vitamin D rises for about 3 months of daily vitamin D3 and then holds at a plateau, near 69 nmol/L at 1,000 IU a day, from a starting level near 41 nmol/L.
In a 3-phase crossover using two deuterium-labelled forms of alpha-tocopherol, healthy women absorbed about 55 percent of an oral dose taken with a 40 percent fat meal and about 64 percent with a fat-free meal, with samples tracked over 72 hours. The authors conclude absorption is not limited by absent fat or fasting, and that vitamin E leaves the intestine by a prolonged process.
A systematic review and Bayesian meta-analysis drew on 108 articles from 14,002 screened records and modelled blood folate against folic acid intake using one-compartment pharmacokinetic models. Red blood cell folate rose 1.78 fold from baseline to steady state at 375 to 570 ug folic acid per day, and reaching that steady state took a median of 36 weeks, 95% credible interval 27 to 52 weeks. Serum or plasma folate rose 11.6% for every 100 ug per day of folic acid intake, 95% credible interval 8.4 to 14.9.
A kinetic study in six healthy men aged 22 to 31 gave 3.6 umol per day, 1.6 mg, of deuterium-labelled folic acid for four weeks, with folate tracked in serum, erythrocytes and urine by microbiological assay and gas chromatography mass spectrometry. Serum folate reached its maximum concentration in about 18 days, while isotopic labelling of erythrocyte folate kept rising across the whole four weeks. After supplementation stopped, red blood cell folate and urinary folate excretion declined linearly, and serum folate fell with a slow-phase half-life of 18.7 days. One study, six men, no control group.
A randomised, double-blind, parallel-group dose-finding trial in 120 older people with mild vitamin B12 deficiency, defined as serum B12 of 100 to 300 pmol/L with methylmalonic acid at or above 0.26 umol/L, gave daily oral cyanocobalamin at 2.5, 100, 250, 500 or 1000 ug for 16 weeks. Mean plasma methylmalonic acid fell 16%, 16%, 23%, 33% and 33% across those doses. Daily doses of 647 to 1032 ug accounted for 80% to 90% of the estimated maximum reduction. The window was measured on a blood marker of B12 status, not on a symptom.
An open-label randomised single-dose pharmacokinetic study in 20 healthy men aged 20 to 45, conducted and authored by staff of Emisphere Technologies, the developer of the SNAC carrier under test, measured serum vitamin B12 after one 5 mg cyanocobalamin tablet, with six men on the marketed tablet. Time to peak serum B12 was 6.83 hours for the marketed tablet and 0.5 hours for the carrier coformulation. Absolute bioavailability was 2.16% and 5.09% respectively. One trial, six men per arm. Serum concentration was measured, not any symptom.
In a randomised single-blind trial, 20 participants took either fish oil supplying 1,296 mg EPA and 864 mg DHA daily or flaxseed oil for eight weeks, with erythrocyte membrane and plasma samples drawn at weeks 0, 4, 8, 10, 12, 14, 16 and 24. On fish oil, erythrocyte membrane EPA rose 300 percent and DHA rose 42 percent by week eight. Levels held until about week 12 and then declined across the post-supplementation sampling, faster in plasma phospholipids than in erythrocyte membranes. Membrane fatty acid content was measured, not a symptom, and this is one trial of 20 people.
In a randomised double-blind crossover trial, healthy men and women aged 19 to 34 took capsules supplying about 4 g DHA per day, with plasma sampled at days 0, 1, 3, 7, 14 and 28. DHA concentrations tripled and so did DHA-derived oxylipins. Increases were detectable as early as day 1, and 11 of 12 individual DHA oxylipins plus total DHA oxylipins reached a plateau by days 5 to 7. The plateau came earlier and was reached by more oxylipins in females than in males. Plasma marker chemistry was measured, not a feeling.
The same eight healthy men then took 10 mg of boron daily with breakfast for seven days, with an 8 a.m. blood draw on day seven. Mean plasma free testosterone increased and mean plasma estradiol decreased significantly, while dihydrotestosterone, cortisol and vitamin D were elevated and all three inflammatory markers fell. The authors describe this as the first human report of a rise in free testosterone after boron intake. There is no placebo arm across the seven days and the sample is eight men, so the one-week figure rests on a single small study.
A double-blind randomised dose-finding trial gave 60 postmenopausal women aged 50 to 69 either 0, 50, 100 or 200 micrograms of menaquinone-7 daily for four weeks on a controlled diet. The ratio of carboxylated to undercarboxylated osteocalcin rose dose dependently, with significant differences from the 0 microgram group at 100 and 200 micrograms. A companion 12-week trial in 120 people aged 20 to 69 confirmed the change at 100 micrograms daily. Both studies were run by authors affiliated with the R and D division of J-Oil Mills. An independent 8-week double-blind trial in 55 healthy prepubertal children found the same direction at 45 micrograms daily. What was measured is a blood marker of vitamin K status, not bone density and not a sensation.
A double-blind randomised trial gave 244 healthy postmenopausal women either placebo or 180 micrograms of menaquinone-7 daily for three years, with bone mineral density measured by DXA at baseline and after each year. Menaquinone-7 decreased the age-related decline in bone mineral content and bone mineral density at the lumbar spine and femoral neck, but not at the total hip. The effect is a slowed decline rather than a gain, and the trial ran three years rather than weeks.
Windows measured in the cited trials. Context for how the active behaves over time, not a statement about any individual and not a claim about this product.
8 ingredients, from each one's own page.
25-hydroxyvitamin D climbs over roughly six to twelve weeks of daily dosing before it plateaus. It's a blood level you watch rather than a feeling.
Plasma alpha-tocopherol climbs within days of daily intake, and anything you'd notice in skin condition is a slow change across a couple of months.
Red cell folate climbs over roughly four to eight weeks. It's a blood panel change rather than a sensation.
Markers move first. Methylmalonic acid and homocysteine start shifting within a week or two, while anything you would notice takes several weeks of daily use.
A looser stool can turn up the same day at the higher end. Sleep and cramp changes usually settle in across two to four weeks, because it is refilling a body-wide store.
Membranes fill slowly. The omega 3 index moves over eight to twelve weeks, and the trials reporting cognitive or eye comfort changes run three to six months.
Plasma boron tracks intake within a day or two because it isn't stored. The change shows up in mineral balance and hormone measures over a week or two.
Days for absorption, weeks for the marker. Undercarboxylated osteocalcin falls across roughly four to twelve weeks of daily intake, and that is a status marker rather than an outcome.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
What each form is, and where it fits in a formula. Measured findings carry the study that reported them.
The animal-sourced form of vitamin D, made in skin under UVB light and produced commercially from lanolin. Fat-soluble, so it travels with dietary fat and is stored in body fat.
In a 12-week double-blind randomised controlled trial in 108 young women in urban Bangalore, most of whom began vitamin D-deficient, daily vitamin D3 at 400, 600 or 800 IU in a fortified wafer raised serum 25-hydroxyvitamin D, parathyroid hormone fell over time, and effects on bone-turnover markers were modest and not dose specific. The 800 IU dose brought 65 percent of participants to sufficiency.
The same (6S)-5-methyltetrahydrofolate molecule paired with glucosamine rather than calcium. Changing the counter-ion changes how the powder behaves, not what the folate is: the glucosamine salt dissolves readily in water, where a calcium salt tends to sit as a suspension, and it comes standardised on a carrier at a declared folate percentage.
A calcium salt of a boron-carbohydrate ester in which boron is diesterified with fructose, matching the sugar-borate complexes boron naturally forms in edible plants.
In a double-blind, placebo-controlled randomised trial of 60 adults with self-reported knee discomfort, 110 mg of calcium fructoborate taken twice daily produced larger within-subject reductions in WOMAC and McGill Pain Questionnaire scores than placebo at both day 7 and day 14.
Descriptions of the form itself, read from the cited studies. Not a comparison between products and not a statement about any individual.
It is a capsule, so the amount per serving is fixed and travels without measuring.
Where two of this brand's products carry actives the literature has read together, the pairing and its basis are below. The evidence word is the corpus row's own confidence, never a score.
D3 absorbs calcium, K2 directs it to bones, Mg activates D3. The complete calcium optimization system.
Because the effect builds and holds only with continued daily use, a steady recurring supply is the practical way to keep it going.
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.